XML 22 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of changes in Stockholders' Equity - USD ($)
Total
Market Offering [Member]
Registered Direct Offering [Member]
Common Stock [Member]
Common Stock [Member]
Market Offering [Member]
Common Stock [Member]
Registered Direct Offering [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Market Offering [Member]
Additional Paid-In Capital [Member]
Registered Direct Offering [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Beginning Balance at Dec. 31, 2018 $ 48,312,566     $ 876     $ 170,207,844     $ (116,855,991) $ (5,040,163)
Beginning Balance (in shares) at Dec. 31, 2018       9,078,238              
Stock based compensation 1,264,231           1,264,231        
Vesting of restricted stock awards including withholding, net (47,120)     $ 6     (47,126)        
Vesting of restricted stock awards including withholding, net (in shares)       (25,691)              
Issuance of common stock, net     $ 12,668,784     $ 436     $ 12,668,348    
Issuance of common stock, net (in shares)           4,361,370          
Issuance of common stock for contingent consideration liability 3,791,485     $ 189     3,791,296        
Issuance of common stock for contingent consideration liability (in shares)       1,887,250              
Issuance of common stock upon exercise of warrants 30,324     $ 1     30,323        
Issuance of common stock upon exercise of warrants (in shares)       11,000              
Unrealized (loss) gain on short-term investments 20,007                   20,007
Net loss (20,520,131)                 (20,520,131)  
Ending Balance at Dec. 31, 2019 45,520,146     $ 1,508     187,914,916     (137,376,122) (5,020,156)
Ending Balance (in shares) at Dec. 31, 2019       15,312,167              
Stock based compensation 2,576,006           2,576,006        
Issuance of common stock from exercise of stock options $ 128,896     $ 4     128,892        
Issuance of common stock from exercise of stock options (in shares) 46,966     46,966              
Vesting of restricted stock awards including withholding, net $ (262,713)     $ 16     (262,729)        
Vesting of restricted stock awards including withholding, net (in shares)       84,320              
Issuance of common stock from Employee Stock Purchase Plan 135,471     $ 8     135,463        
Issuance of common stock from Employee Stock Purchase Plan (in shares)       92,661              
Issuance of common stock and pre-funded warrants in public offering, net 124,027,815     $ 412     124,027,403        
Issuance of common stock and pre-funded warrants in public offering, net (in shares)       4,119,564              
Issuance of common stock, net   $ 48,156,072     $ 560     $ 48,155,512      
Issuance of common stock, net (in shares)         5,594,455            
Issuance of common stock for contingent consideration liability 13,625,010     $ 169     13,624,841        
Issuance of common stock for contingent consideration liability (in shares)       1,694,906              
Issuance of common stock upon exercise of warrants 41,038,458     $ 1,020     41,037,438        
Issuance of common stock upon exercise of warrants (in shares)       10,197,907              
Unrealized (loss) gain on short-term investments (24,361)                   (24,361)
Net loss (49,044,477)                 (49,044,477)  
Ending Balance at Dec. 31, 2020 $ 225,876,323     $ 3,697     $ 417,337,742     $ (186,420,599) $ (5,044,517)
Ending Balance (in shares) at Dec. 31, 2020       37,142,946